NCT01063894

Brief Summary

The objective of this study is to test the effects of breakfast on cognitive processing ability in children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
291

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 5, 2010

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

February 20, 2020

Status Verified

August 1, 2015

Enrollment Period

4 months

First QC Date

February 4, 2010

Last Update Submit

February 18, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of Memory and Attention based on results using CDR System

    4 hours following breakfast

Secondary Outcomes (1)

  • Speed of Memory and Attention based on results using CDR System

    4 hours following breakfast

Study Arms (2)

breakfast cereal

EXPERIMENTAL

breakfast cereal and milk

Other: breakfast cereal

water

PLACEBO COMPARATOR

water

Other: water

Interventions

breakfast cereal and milk

breakfast cereal
waterOTHER

water

water

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Subject is willing to maintain their habitual diet and physical activity patterns throughout the study period
  • Provision of assent by subject
  • Subject's guardian provides informed consent to participate in the study and authorization for release of relevant protected health information to the study investigators

You may not qualify if:

  • Diagnosis of attention deficit disorder, with or without hyperactivity
  • A diagnosis of diabetes mellitus
  • Acute illness or use of antibiotics within 5 days of visit
  • Subject is a non-breakfast eater defined as not regularly eating food prior to 1000 h
  • Known sensitivity or allergy to any ingredients of the study product
  • Use of any psychotropic medication within 4 weeks
  • Subject did not previously participate in an earlier trial with the same study products
  • Exposure to investigational agent within 30 days.
  • Individual has a condition the Investigator believes would interfere with his or her ability to provide assent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Provident Clinical Research

Addison, Illinois, 60101, United States

Location

MeSH Terms

Interventions

Water

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • Kevin Maki, Ph.D.

    Provident Clinical Research

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2010

First Posted

February 5, 2010

Study Start

December 1, 2009

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

February 20, 2020

Record last verified: 2015-08

Locations